Shares of IXICO plc (LON:IXI – Get Free Report) fell 11.5% during mid-day trading on Wednesday . The stock traded as low as GBX 10.84 ($0.14) and last traded at GBX 10.84 ($0.14). 673,751 shares traded hands during mid-day trading, an increase of 812% from the average session volume of 73,851 shares. The stock had previously closed at GBX 12.25 ($0.16).
IXICO Trading Down 11.5 %
The stock has a fifty day simple moving average of GBX 9.81 and a 200 day simple moving average of GBX 8.49. The company has a debt-to-equity ratio of 3.22, a quick ratio of 4.90 and a current ratio of 3.64. The firm has a market cap of £5.24 million, a P/E ratio of -306.25, a price-to-earnings-growth ratio of -0.38 and a beta of 0.86.
Insider Buying and Selling
In related news, insider Mark Warne bought 26,370 shares of the firm’s stock in a transaction on Thursday, October 10th. The stock was acquired at an average cost of GBX 9 ($0.11) per share, for a total transaction of £2,373.30 ($3,007.22). 30.28% of the stock is owned by corporate insiders.
IXICO Company Profile
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.
Further Reading
- Five stocks we like better than IXICO
- 3 Best Fintech Stocks for a Portfolio Boost
- 2 Off-Price Retail Titans: Which Stock Has More Upside in 2025?
- Top Stocks Investing in 5G Technology
- Kohl’s Faces Holiday Hurdles, But Key Factors Offer Hope
- How to Invest in Small Cap Stocks
- Dogs of the Dow: 3 Stocks Poised for a 2025 Rebound
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.